Helicon Group Limited is listed on the Australian Securities Exchange. The Company’s business is to identify and exploit niche market opportunities in the Biomedical markets in selected Asian markets with a China priority and to participate in the significant growth that has been projected for these markets over the next 25 years.
The Mission of the Helicon Group is to be a trusted vehicle and partner into the high end of the China and other selected Asian markets for innovative Western Biomedical products developed by small to medium sized research based pharmaceutical and medical device companies.
HOME
COMPANY